Catabasis Pharmaceuticals Inc Share Price Nasdaq
Equities
US14875P1075
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 527M 41.42B |
---|---|---|---|---|---|
Net income 2024 * | -90M -7.08B | Net income 2025 * | -111M -8.73B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.49
x | P/E ratio 2025 * |
-5.45
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.7% |
Latest transcript on Catabasis Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 25/06/08 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 31/03/11 |
Chief Tech/Sci/R&D Officer | - | 14/07/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 31/12/13 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 03/01/19 |
Director/Board Member | 75 | 04/04/16 |
1st Jan change | Capi. | |
---|---|---|
+9.58% | 115B | |
+12.41% | 107B | |
-3.52% | 21.6B | |
-12.38% | 22.31B | |
-6.87% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |